Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits

被引:6
作者
Hamieh, Al Mahdy [1 ]
Babin, David [1 ]
Sable, Evelyne [1 ]
Hernier, Anne Marie [1 ]
Castagne, Vincent [1 ]
机构
[1] Porsolt SAS, ZA Glatigne, F-53940 Le Genest St Isle, France
关键词
Schizophrenia; Animal models; Neonatal PCP; Social isolation; Locomotor activity; Working memory; Prepulse inhibition; Executive functions; Clozapine; NEGATIVE SYMPTOMS; ANIMAL-MODELS; NEURODEVELOPMENTAL HYPOTHESIS; PREFRONTAL CORTEX; MEMORY DEFICITS; WORKING-MEMORY; SCHIZOPHRENIA; PCP; REVERSAL; INSIGHTS;
D O I
10.1007/s00213-020-05700-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale There is a need to develop animal models of schizophrenia-like behaviors that have both construct and predictive validity. Recently, a neonatal phencyclidine (PCP) and post-weaning social isolation dual-hit model was developed; however, its face and predictive validities need to be further investigated. Objective The aims of this study were to extend the characterization of the behavioral changes occurring in the neonatal PCP and post-weaning social isolation dual-hit rat model and to evaluate the effects of chronic treatment with clozapine on signs related to schizophrenia. Methods Male Wistar rat pups were treated with PCP (10 mg/kg s.c.) on postnatal days (PND) 7, 9, and 11. Starting from weaning, neonatal PCP-treated rat pups were socially isolated, while control saline-treated rats were group housed. At adulthood, rats were assessed using behavioral tasks evaluating locomotor activity, social recognition, prepulse inhibition, and reversal learning. Clozapine (3 mg/kg i.p.) was administered daily starting from a week before behavioral tests and until the end of the study. Results Neonatal PCP-treated and post-weaning social isolated (PCP-SI) rats displayed persistent and robust locomotor hyperactivity as well as social recognition impairment. The latter could not be explained by variations in the motivation to interact with a juvenile rat. Weak-to-moderate deficits in prepulse inhibition and reversal learning were also observed. Chronic treatment with clozapine attenuated the observed locomotor hyperactivity and social recognition deficits. Conclusion The PCP-SI model presents enduring and robust deficits (hyperactivity and social recognition impairment) associated with positive symptoms and cognitive/social deficits of schizophrenia, respectively. These deficits are normalized by chronic treatment with clozapine, thereby confirming the predictive validity of this animal model.
引用
收藏
页码:517 / 528
页数:12
相关论文
共 54 条
[1]   Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions [J].
Addy, NA ;
Pocivavsek, A ;
Levin, ED .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (06) :1121-1127
[2]   Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups [J].
Anastasio, Noelle C. ;
Johnson, Kenneth M. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 90 (04) :569-577
[3]   Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine [J].
Andersen, JD ;
Pouzet, B .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (06) :1080-1090
[4]   Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs [J].
Basta-Kaim, Agnieszka ;
Szczesny, Ewa ;
Leskiewicz, Monika ;
Glombik, Katarzyna ;
Slusarczyk, Joanna ;
Budziszewska, Boguslawa ;
Regulska, Magdalena ;
Kubera, Marta ;
Nowak, Wojciech ;
Wedzony, Krzysztof ;
Lason, Wladyslaw .
PHARMACOLOGICAL REPORTS, 2012, 64 (06) :1400-1410
[5]   Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: Effects of antipsychotic drugs [J].
Basta-Kaim, Agnieszka ;
Budziszewska, Boguslawa ;
Leskiewicz, Monika ;
Fijal, Katarzyna ;
Regulska, Magdalena ;
Kubera, Marta ;
Wedzony, Krzysztof ;
Lason, Wladyslaw .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 650 (2-3) :586-595
[6]   Oligodendrocytes: Potential of Discovering New Treatment Targets [J].
Brandao-Teles, Caroline ;
de Almeida, Valeria ;
Cassoli, Juliana S. ;
Martins-de-Souza, Daniel .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[7]  
BREIER A, 1994, AM J PSYCHIAT, V151, P20
[8]   Evaluation of a neurodevelopmental model of schizophrenia - Early postnatal PCP treatment in attentional set-shifting [J].
Broberg, Brian Villumsen ;
Dias, Rebecca ;
Glenthoj, Birte Yding ;
Olsen, Christina Kurre .
BEHAVIOURAL BRAIN RESEARCH, 2008, 190 (01) :160-163
[9]   Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine [J].
De Berardis, Domenico ;
Rapini, Gabriella ;
Olivieri, Luigi ;
Di Nicola, Domenico ;
Tomasetti, Carmine ;
Valchera, Alessandro ;
Fornaro, Michele ;
Di Fabio, Fabio ;
Perna, Giampaolo ;
Di Nicola, Marco ;
Serafini, Gianluca ;
Carano, Alessandro ;
Pompili, Maurizio ;
Vellante, Federica ;
Orsolini, Laura ;
Martinotti, Giovanni ;
Di Giannantonio, Massimo .
THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 9 (05) :237-256
[10]  
den Buuse MV, 2003, CURRENT MOL MED